Ligneous 发表于 2025-3-23 11:11:33

http://reply.papertrans.cn/2/113/11210/11210-11.png

Anguish 发表于 2025-3-23 15:51:46

http://reply.papertrans.cn/2/113/11210/11210-12.png

Carminative 发表于 2025-3-23 20:38:19

http://reply.papertrans.cn/2/113/11210/11210-13.png

尊严 发表于 2025-3-24 00:59:19

Submitted on: 23 January 2012.
Revised on: 07 May 2012.
Accepted on: 30 June 2012.

___________________Hematology Transfusion and Cell Therapy

OTTER 发表于 2025-3-24 05:06:03

Submitted on: 05 October 2018.
Revised on: 12 November 2018.
Accepted on: 08 January 2019.

___________________Hematology Transfusion and Cell Therapy

喧闹 发表于 2025-3-24 08:29:10

Submitted on: 07 September 2023.
Revised on: 05 October 2023.
Accepted on: 01 December 2023.

___________________Hematology Transfusion and Cell Therapy

degradation 发表于 2025-3-24 14:43:37

http://reply.papertrans.cn/2/113/11210/11210-17.png

opalescence 发表于 2025-3-24 15:07:08

http://reply.papertrans.cn/2/113/11210/11210-18.png

搜寻 发表于 2025-3-24 19:04:52

Submitted on: 19 August 2011.
Revised on: 02 December 2011.
Accepted on: 17 December 2011.

___________________Hematology Transfusion and Cell Therapy

沉思的鱼 发表于 2025-3-25 02:12:27

Submitted on: 07 April 2021.
Revised on: 13 May 2021.
Accepted on: 30 June 2021.

___________________Hematology Transfusion and Cell Therapy
页: 1 [2] 3 4
查看完整版本: ESCI期刊Hematology Transfusion and Cell Therapy 2024/2025影响因子:1.876 (HEMATOL TRANSF CELL) (2531-1379). (HEMATOLOGY)(血液学)E